Adastra Holdings Ltd. (XTRX.CN)
| Previous Close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.6100 x N/A |
| Ask | 0.6600 x N/A |
| Day's Range | 0.6000 - 0.6000 |
| 52 Week Range | 0.5000 - 1.6000 |
| Volume | |
| Avg. Volume | 6,804 |
| Market Cap | 39.582M |
| Beta (5Y Monthly) | -0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0550 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Adastra Holdings Announces New Director
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the appointment of Smoke Wallin to the Company's board of directors.
- CNW Group
Adastra Holdings Announces 2021 Annual Financial Results and Corporate Update
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") is pleased to announce that it has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021, both of which are available at www.sedar.com.
- CNW Group
Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Services
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the submission of its Medical Sales License application to Health Canada on April 1, 2022.
